Jared Kelly

Jared Kelly

Chief Executive OfficeratOncolytics Biotech· In the 2025 proxy

Pay in FY2025Oncolytics Biotech stock -4.4% the same year

Jared Kelly was paid $2.1M in FY2025 (Dec). Oncolytics Biotech stock fell 4.4% that year.

Pay$100 in the stock at the end of FY24 → $96
Pay is from the Summary Compensation Table of each Oncolytics Biotech proxy. The stock line is the value of $100 put in the stock at the start, from the price change of each fiscal year. Dividends are not in it.

Experience

  1. Oncolytics BiotechPublic company · 1 yr
    • Chief Executive Officer2025 – Present · 1 yrStock in role -54%

Roles come from the proxy statements of each company.

Activity

No new filings about this person in the feed.

For the press:Download CSVDownload PNGHow to use our data

Two people shown as one, or a wrong number?